AXA Investment Managers’s AstraZeneca AZN Stock Holding History

AXA Investment Managers’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$36.2M	Buy	+235,798	New	+$35.7M	0.1%	184

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AXA Investment Managers's AZN Position: Q3 2025 in Review

AXA Investment Managers opened a new position in AstraZeneca (AZN) in Q3 2025: 235,798 shares worth $36.2M. The stake represents 0.1% of the portfolio and ranks #184 among its holdings.

1,287 funds tracked by Wall St. Rank hold AZN as of Q3 2025.

AXA Investment Managers held 235,798 shares of AstraZeneca worth $36.2M as of Q3 2025.
AstraZeneca was a new AXA Investment Managers position in Q3 2025.
AstraZeneca made up 0.1% of AXA Investment Managers's portfolio in Q3 2025, its #184 holding.
1,287 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2025.

Based on AXA Investment Managers's 13F filing for Q3 2025, filed 14 Nov 2025.